Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Chimerix to Present at Cowen and Company 42nd Annual Health Care Conference
-
Chimerix to Present at Cowen and Company 2nd Annual Virtual Oncology Innovation Summit
-
Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
-
Chimerix (CMRX) Prices 11.765M Share Common Offering at $8.50/Sh
-
Chimerix Announces Pricing of Public Offering of Common Stock
-
Chimerix (CMRX) Announces Proposed $75M Public Offering of Common Stock
-
Chimerix Announces Proposed $75,000,000 Public Offering of Common Stock
-
Chimerix to Present at Cowen and Company 40th Annual Health Care Conference
-
Chimerix to Present at Cowen and Company 39th Annual Health Care Conference
-
Pre-Open Stock Movers 02/22: (W) (XOG) (VYGR) Higher (STMP) (KHC) (DBX) Lower (more...)
-
Chimerix to Present at Cowen and Company 38th Annual Health Care Conference
-
Chimerix to Present at Cowen and Company 37th Annual Health Care Conference
-
Chimerix to Present at Cowen and Company 36th Annual Health Care Conference
-
Notable Analyst Rating Changes 12/29: (TGI) (PRMW) Upgraded; (CMRX) (TAT) (AVGR) Downgraded
-
Cowen Downgrades Chimerix (CMRX) to Market Perform; $8 PT
-
Chimerix Announces Exercise in Full of Option to Purchase Additional Shares of Common Stock
-
Chimerix (CMRX) Prices 3.78M Offering at $39.75/Share
-
Chimerix Prices Public Offering of Common Stock
-
Chimerix (CMRX) Closes 4.2M Common Offering
-
Chimerix (CMRX) Announces $105M Common Stock Offering
-
Chimerix (CMRX) Commences 6.2M Share Offering
-
Notable Analyst Rating Changes 05/06: (CLF) (CBL) (INTC) Upgraded; (EGO) (EXC) (SPRD) Downgraded
-
Cowen Starts Chimerix (CMRX) at Outperform
-
Chimerix (CMRX) IPO Opens Higher
-
Chimerix (CMRX) Prices Up-Sized IPO at $14
-
Chimerix (CMRX) Sees IPO Price of $13 - $15/Share
-
Chimerix (CMRX) Files $85M IPO

